Biosecurity and the New Order

Amid the flurry of executive orders, chain saws and performative policymaking, regulatory progress and adverse developments in global health persist.   We share perspective on biological weaponry in the time of AI, an update on dual-use biologics rules and pending changes, a discussion of the emergence of China in drug discovery, and efforts to reduce drug prices which may lead to new export controls.